Cancer immunotherapies can save millions of lives
But lack of testing can lead to
severe side effects like
autoimmune response
#00
How Do We Ensure Safety?
#01
Prevent Toxicity
In silico toxicity assessments enable rapid identification of potentially harmful compounds, significantly reducing the need for extensive lab testing and enhancing safety profiles early in drug development
#02
Ensure Specificity
Evaluating specificity through in silico models ensures that cancer immunotherapies target only the intended cells, minimizing off-target effects and improving therapeutic efficacy
#03
Predict CRS
In silico assessment of cytokine release syndrome (CRS) helps predict immune responses to therapies, allowing for better management strategies and reducing the risk of severe adverse effects in patients
Benefits
#01
Safety ++
High-throughput testing for dangerous side effects
#02
Speed ++
Deliver therapies faster as every moment counts
#03
Cost --
Reduce testing cost without compromising patient safety